Kenya ePrescription Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya ePrescription Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/Kenya-ePrescription-IG/ and changes regularly. See the Directory of published versions

: MedicationStatement – Amina Hassan Completed Azithromycin Course - JSON Representation

Raw json | Download

{
  "resourceType" : "MedicationStatement",
  "id" : "example-medicationstatement-amina-azithromycin",
  "meta" : {
    "profile" : [
      🔗 "https://fhir.dha.go.ke/erx/StructureDefinition/ke-medication-statement",
      "https://fhir.dha.go.ke/fhir/StructureDefinition/ke-medication-statement"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Medication Statement MEDS-2025-00234</b></p><p>Amina Hassan completed a 3-day course of Azithromycin 500 mg (15–17 June 2025), recorded at KNH outpatient consultation. Status: completed. Asserted: 18 June 2025.</p></div>"
  },
  "identifier" : [
    {
      "system" : "https://ilm-hie.dha.go.ke/fhir/NamingSystem/medstatement-identifier",
      "value" : "MEDS-2025-00234"
    }
  ],
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "https://fhir.dha.go.ke/fhir/CodeSystem/generic-products-cs",
        "code" : "GE10015",
        "display" : "Azithromycin 500 mg Oral Tablet"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/example-patient-amina"
  },
  "context" : {
    🔗 "reference" : "Encounter/example-encounter-amina-outpatient"
  },
  "effectivePeriod" : {
    "start" : "2025-06-15",
    "end" : "2025-06-17"
  },
  "dateAsserted" : "2025-06-18",
  "informationSource" : {
    🔗 "reference" : "Patient/example-patient-amina"
  },
  "note" : [
    {
      "text" : "Patient confirmed completing the full 3-day course without missing a dose. No adverse effects reported."
    }
  ],
  "dosage" : [
    {
      "text" : "1 tablet (500 mg) orally once daily for 3 days",
      "timing" : {
        "repeat" : {
          "frequency" : 1,
          "period" : 1,
          "periodUnit" : "d"
        }
      },
      "route" : {
        "coding" : [
          {
            "system" : "https://fhir.dha.go.ke/fhir/CodeSystem/route-of-administration-cs",
            "code" : "RT10025",
            "display" : "Oral"
          }
        ]
      }
    }
  ]
}